Epic Research

Thursday, December 20, 2012

Epic Update : Lupin

Lupin Pharmaceuticals Inc (collectively Lupin) has received final approval for its Drospirenone and Ethinyl Estradiol Tablets, 3 mg / 0.03 mg from the United States Food and Drugs Administration (USFDA) to market a generic version of Bayer Healthcare’s (Bayer) Yasmin Tablets 3 mg / 0.03 mg.  As per IMS MAT Sept 2012 sales, Yasmin Tablets had annual US sales of approximately $275.1 million.

Get Free Penny Stock Tips,MCX Tips,Stock Tips,Forex TipsNCDEX Tips,Commodity Tips,Share Tips,commodity tips free trial, nifty free tips,commodity trading tips, shares tips, ShareMarket Tips, Stock Market Tips, free stock tips on mobileStock trading tips,Intraday Tips.

No comments:

Post a Comment